Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar, Depression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01072630
What this trial is testing

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 492
Not applicableUnknownNCT03862209
What this trial is testing

Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia

Who this might be right for
Severe Mental DisorderSchizophreniaBipolar Disorder+1 more
Klinički Bolnički Centar Zagreb 200
Not applicableNot Yet RecruitingNCT06115200
What this trial is testing

Norwegian Adult Mental Health Registry

Who this might be right for
DepressionSchizophreniaBipolar Disorder+5 more
Helse Stavanger HF 150,000
Not applicableStudy completedNCT05603819
What this trial is testing

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Alcediag 418
Post-approval studies (Phase 4)Study completedNCT01881763
What this trial is testing

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Who this might be right for
Unipolar DepressionBipolar Depression
Northwell Health 31
Not applicableStudy completedNCT06516991
What this trial is testing

Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder

Who this might be right for
Bipolar Depression
First Affiliated Hospital of Zhejiang University 36
Not applicableStudy completedNCT00485420
What this trial is testing

ECare for Moods: An Internet-based Management Program

Who this might be right for
Major Depressive DisorderBipolar Disorder
Kaiser Permanente 404
Post-approval studies (Phase 4)Ended earlyNCT03643159
What this trial is testing

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Who this might be right for
SchizophreniaBipolar 1 DisorderMajor Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT02974010
What this trial is testing

Sequential Therapy for the Treatment of Severe Bipolar Depression.

Who this might be right for
Bipolar DepressionSuicidal IdeasSuicidal Ideation+1 more
NeuroRx, Inc. 22
Early research (Phase 1)Study completedNCT00988949
What this trial is testing

Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release

Who this might be right for
Bipolar Depression
Pfizer 24
Not applicableStudy completedNCT00001174
What this trial is testing

Evaluation of the Genetics of Bipolar Disorder

Who this might be right for
Bipolar Disorder
National Institute of Mental Health (NIMH) 4,210
Not applicableUnknownNCT05608135
What this trial is testing

AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder

Who this might be right for
Bipolar Disorder DepressionMajor Depression
First Affiliated Hospital of Zhejiang University 960
Testing effectiveness (Phase 2)Study completedNCT00001482
What this trial is testing

New Drugs in the Treatment of Mood Disorders

Who this might be right for
Anxiety DisorderMood DisorderPsychotic Disorder
National Institute of Mental Health (NIMH) 60
Testing effectiveness (Phase 2)Study completedNCT03913013
What this trial is testing

Technology Enhanced Family Treatment

Who this might be right for
Mood DisordersBipolar DisorderMajor Depression
University of California, Los Angeles 65
Large-scale testing (Phase 3)Study completedNCT01403662
What this trial is testing

Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Depression+1 more
University Health Network, Toronto 29
Not applicableStudy completedNCT02553161
What this trial is testing

Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth

Who this might be right for
DepressionAnxietyBipolar Disorder
University of Cincinnati 214
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Not applicableStudy completedNCT06126198
What this trial is testing

RTMS Feasibility Study on Adolescent Depression Stimulation

Who this might be right for
Major Depressive DisorderUnipolar DepressionBipolar Depression
Uppsala University 20
Post-approval studies (Phase 4)Study completedNCT00845507
What this trial is testing

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

Who this might be right for
Weight Gain
University of Cincinnati 54
Testing effectiveness (Phase 2)Study completedNCT05029466
What this trial is testing

Psilocybin for Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
Brain and Cognition Discovery Foundation 30
Next Page